INTRODUCTION
The differentiation of macrophages from bone marrow progenitors requires the coordinated expression of many genes needed for mature cell function. This process is controlled by the lineage-specific growth factor, macrophage colony-stimulating factor (CSF-1), which acts by binding to cell surface receptors (CSF-1R) encoded by the c-fms protooncogene 1 . We 2-4 and others 5, 6 have studied the transcriptional regulation of the c-fms gene as a route to understanding lineage commitment in the macrophage lineage. The c-fms mRNA is detectable in the earliest yolk-sac phagocytes formed during mouse development, prior to many other markers including the macrophage-restricted transcription factor, PU.1, and the expression in the embryo and adult mouse is largely restricted to cells of the macrophage lineage 7, 8 . The only other major site where c-fms gene is expressed is in placental trophoblasts 9, 10 . In humans, there is a trophoblast-specific
promoter that lies at the 3' end of the PDGFR-gene, some 20kb upstream of the first coding exon 5, 11 .
The murine exon 2 c-fms promoter was more active in transient transfections of a macrophage cell line, RAW264, than in untransformed fibroblasts 12 , but it was also active in a wide range of tumour cell lines that do not express the full length endogenous mRNA 3, 13 . Tumour cells in which the promoter was active were shown to produce c-fms transcripts that contained exon 2 and extended into the downstream intron 2, but did not have detectable full length c-fms mRNA.
Inclusion of intron 2 in reporter gene constructs abolished reporter gene expression in nonmacrophage tumor cells, but significant activity was retained in RAW264 macrophages 3 . We showed elsewhere that intron 2 contains a DNase 1 hypersensitive site we refer to as the Fms Intronic Regulatory Element (FIRE). FIRE was required for maximal expression of a reporter gene in stably-transfected RAW264 macrophages 4 . The intronic sequence without FIRE actually profoundly suppressed reporter gene expression driven by the exon 2 promoter 4 .
only.
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In this paper, we show that the proximal promoter of c-fms combined with the first intron directed consistent expression of the EGFP reporter gene in the same locations as the endogenous gene, and appropriate expression required the intronic elements described previously. We demonstrate that the fms-EGFP reporter gene provides a definitive marker for cells of the mononuclear phagocyte lineage throughout embryonic development, in the bone marrow and peripheral blood and in all adult tissues. These findings provide a framework for the use of the cfms promoter in applications where targeted manipulation of macrophage or trophoblast differentiation in transgenic animals is desired.
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METHODS
Analysis of c-fms transcripts in placental RNA
Total RNA was extracted from embryonic day 14 (e14) placenta as described 9 . Aliquots were subjected to four sets of 5'RACE experiments according to the manufacturer's instructions (Invitrogen) using reverse orientation (3' 5') primers located in exon 2. Primer sequences for 5'RACE experiments are described in Table 1 . Products of the reactions were cloned into a TA vector (Invitrogen) and sequenced. Mouse c-fms sequence accession number was AF290879.
To construct a representative placental library, poly A + selected e14 placental RNA was converted into cDNA using both random and Oligo dT priming. This cDNA was cloned into a Zap vector (Clontech). Average library insert size was 1.5kb and its complexity was 1.5 X 10 6 independent clones. This library was probed with a [ 32 P]-dCTP labelled full-length c-fms cDNA in the first round followed by a c-fms exon 2 probe in the second round. The 5'-ends of the selected inserts were sequenced.
For Northern blot analysis, 20 µg of total RNA was separated by formaldehyde-agarose gel electrophoresis, transferred to nylon filters and probed with a [ 32 P]-dCTP labelled cDNA probe specific for exon 1 or 2 of c-fms. Samples included RNA from trophoblastic stem cells (TS) 14 (generously provided by Dr. Janet Rossant, Toronto, Canada), a macrophage cell line (BAC1.2F5) 15 , and e10 and e14 placentae all of which are c-fms positive 9,10 as well as the c-fms negative L-cell line and mouse embryo fibroblasts (MEF).
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Plasmid constructs
Some of the reporter constructs that were used in this study have been described previously 3 , except that luciferase gene was replaced by enhanced variant of the Green Fluorescent Protein (EGFP) gene derived from pEGFP-N1 vector (Clontech). Briefly, the constructs used were 3.5kb
sequence flanking mouse c-fms exon 2 driving the EGFP gene (p3.5fms-EGFP), the 3.5kb exon 2 promoter plus the whole intron 2 sequence driving the EGFP gene (p7.2fms-EGFP), and p7.2fms-EGFP with the deletion of conserved FIRE region on intron 2 driving the EGFP gene (p7.2fms FIRE-EGFP). The 7.2fms promoter has been renamed from 6.7fms, to reflect accurate sizing based upon the full length sequence (AF290879). All plasmids were prepared on QIAGEN affinity columns according to the manufacturer's instructions. For generation of transgenic mice, plasmid backbones were removed by restriction digestions, and the transgenes used for DNA injection were gel-purified by using QIAquick gel extraction kit (QIAGEN, Clifton Hill, Victoria).
Generation of transgenic mice
Transgenic (TG) mice were generated at Transgenic Animal Service of Queensland (www.tasq.uq.edu.au) by injection of the transgenes into pronuclei of BCBF1 fertilised eggs. TG mice generated were maintained under specific pathogen-free environment. The integration of the transgenes was investigated by PCR analysis of tail biopsy DNA, amplifying the EGFP gene by using primers 5'-CTGGTCGAGCTGGACGGCGACG-3' (forward) and 5'-CACGAACTCCAGCAGGACCATG-3' (reverse). The amplification temperatures were 1 min 95°C, 1 min 60°C, and 1 min 72°C for 25 cycles after an initial denaturing step of 5 min 95°C.
Southern blot analyses were also conducted on genomic DNAs of some mice for confirmation of genotype using standard protocols.
Cells and Tissue culture
Peritoneal macrophages (TEPM) were isolated from peritoneal cavities after i.p. injections of 1 mL of 10% thioglycollate broth, followed by peritoneal lavage with PBS 3-4 days later.
Pulmonary macrophages were obtained from broncho-alveolar lavage (BAL), while bone marrow-derived macrophages (BMM) were obtained by isolation of bone marrow cells from the femurs of adult mice followed by differentiation of cells in the complete RPMI medium (Invitrogen) supplemented with 10% fetal bovine serum (Serum Supreme, BioWhittaker, Walkersville, MD) and 2mM L-glutamine (Glutamax, Invitrogen), 20 U/mL penicillin, 20 µg/mL streptomycin (Invitrogen) and 100 U/mL of CSF-1 (Chiron Corp) for seven days 16 . For dualcolour FACS analysis of splenocytes ( Fig. 5A ) using Mac-1 (CD11b) and F4/80 antibodies, spleen cells were mechanically disaggregated by mincing the tissues using sterile scalpel blades.
Spleen adherent cells were enriched by overnight incubation on bacteriological petri dishes, to which they adhere weakly, followed by removal of the TC media and floating cells. The remaining adherent cells were harvested by squirting the petri dish surface with medium using a 20mL syringe and 18G needle, and subjected to FACS analysis after washing in PBS. For FACS analysis of tissue macrophages in spleen, liver, and lung, enzymatic digestions were performed with 0.1U/mL Collagenase and 0.8U/mL Dispase (Roche) in PBS/20% FCS 7 for 1h at 37°C.
Dispersed cells were washed in PBS and strained through 100µm cell strainers (BD Falcon) and single cell suspensions were subjected to FACS. For isolation of cells from intestinal lamina propria, epithelial cells were washed in Calcium-and Magnesium-free Hanks' Balanced Salt Solution (Invitrogen) and minced tissues were enzymatically digested as described for other tissues above. Disaggregated cells were separated into low-and high-density fractions via centrifugation on Nycodenz (Nycomed Pharma, Norway) gradient prior to FACS analysis 17 .
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Transgenic animal characterisation.
The 7.2fms-EGFP was microinjected into mouse embryos by standard methods, and progeny were screened for incorporation of the transgene by PCR and Southern blot (data not shown). Six transgenic lines were produced, but one did not transmit the transgene. For all of the 7.2fms-EGFP transgenic lines, EGFP was detected readily in peritoneal, bone marrow-derived and broncho-alveolar lavage macrophages (Fig. 3B ). The level of EGFP expression in macrophages from three lines tested by flow cytometry was remarkably consistent (Table 2) .
Intron 2 as well as the FIRE region required for the activity of the transgene in vivo.
In stable transfections of macrophage line RAW264, removal of the first intron greatly reduced EGFP expression, and removal of the FIRE sequence abolished it 4 . To extend these observations, we produced 4 independent transgenic lines with constructs using the 3.5kb
promoter alone, and 6 independent lines with the 7.2kb promoter without the FIRE sequence. By contrast to the thioglycollate-elicited peritoneal macrophages (TEPM) or BMM from the 7.2fms-EGFP transgenic mice, those obtained from lines expressing EGFP from the 3.5kb promoter exhibited fluorescence in a smaller number of cells and at much lower level (Fig. 3B , upper row and Table 2 ). On tissue sections of these transgenic mice, the level of EGFP was below the limits of detection (not shown). Deletion of the FIRE region completely abolished the activity of the transgene in these macrophage populations in each of the 6 transgenic lines examined (Fig. 3B, only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From lower row and Table 2 ). Again, there was no detectable expression of EGFP in tissue sections of any of the transgenic lines produced with the 7.2fms FIRE-EGFP transgene. The data indicate that the intron, and particularly the FIRE sequence, is absolutely needed for the reproducible, position independent expression, obtained with the 7.2fms-EGFP transgene.
c-fms/EGFP transgene is active in Trophoblasts
The analysis of the start site above suggests that the 3.5kb fms promoter could direct trophoblast expression. In order to assess the possible activities of the c-fms promoter driving the EGFP reporter gene in these cells, EGFP expression in early embryonic development was determined.
Fluorescence microscope observation of 7.2fms-EGFP TG embryos revealed the presence of green-fluorescent cells in the ectoplacental cone area of e7.5 embryos. Later in development, trophoblasts in the deciduum surrounding the embryo were also positive for EGFP, as were in trophoblastic giant cells in e10.5 and e12.5 embryo (not shown). The locations of the EGFP + cells in these embryos were similar to the expression of c-fms mRNA detected by in situ hybridisation 8, 20 . The expression of the EGFP in trophoblasts was also observed in giant cells grown in tissue-culture plates derived from the ectoplacental cones (Fig.4A ). These observations support the data from the start site analysis, and demonstrated that the exon 2 c-fms upstream promoter region in the mouse is used by both macrophage lineage and trophoblast cells.
EGFP is widely expressed in phagocytic cells in tissues of the transgenic embryos.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From 14 Our laboratory has previously described the analysis of c-fms gene expression by whole-mount in situ hybridisation in mouse embryonic development 7, 8 . The ability of the 7.2fms-EGFP transgene to recapitulate c-fms mRNA expression was examined systematically. The first c-fms-expressing cells were detected in the yolk sac around e9.5 and the location is recapitulated by EGFP + cells.
Their abundance and distribution is striking. They are not focussed in blood islands, but distributed throughout the yolk sac (Fig. 4B ). There is no possibility that the green-fluorescent cells observed in the yolk sac originated from infiltration of cells of maternal origin because all the embryos examined were derived from non-transgenic mothers mated with a transgenic male.
The origin and function of these yolk sac derived embryonic phagocytes has been reviewed recently 21 . By e10-10.5, significant numbers of EGFP + cells were observed infiltrating first into the head, then the liver of the embryo (not shown), again entirely consistent with the published pattern of c-fms mRNA expression 7 and independent evidence of the infiltration of haematopoietic progenitors and stem cells into the liver which occurs at e10.5-11 22 . The number of green-fluorescent cells escalated rapidly through development of the embryo to e12-13. In upon which surface CSF-1R was undetectable was smaller than in marrow (Fig 5B) . Fig. 5C shows the expression of CD11b and F4/80 on EGFP + peritoneal and broncho-alveolar lavage cells. All EGFP + cells in the peritoneum express both markers. By contrast, alveolar only.
For populations of the body. In the spleen, the red pulp macrophages were strongly EGFP + (Fig. 6A ).
Enzymatic digestion of the spleen followed by flow cytometry revealed approximately 18% of cells that were EGFP + . The majority of these cells adhered to bacteriological plastic, supporting their identity as macrophages (Fig. 5A) . Similarly, in liver EGFP was expressed specifically on sinusoidal stellate cells, resembling liver macrophages (Kupffer cells) with the characteristic concentration towards the periphery of liver lobules. In this organ, these cells constituted about 8-9% of the whole liver cells, as examined by FACS analysis following enzymatic disaggregation (Fig. 6B ). In the lung there is a large interstitial macrophage population in addition to those present in broncho-alveolar spaces 33 . EGFP expression was detected on 8% of cells from enzymatically-digested lung (Fig. 6C) . Finally, in the intestinal lamina propria there is a large population of macrophages that can be isolated following enzymatic digestion. Fig. 6D shows tissue section and the FACS profile of enzymatically-digested mouse intestinal wall, where 6-8% of cells were EGFP + . Nycodenz gradient centrifugation of this digested tissue could increase the proportion of EGFP + cells up to 15%, consistent with previous studies on purification of these cells 17 .
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Macrophages and c-fms expression in brain are of particular interest because of the neurological abnormalities in the CSF-1-deficient Csf1 op /Csf1 op mouse 34 and the isolated claim that the human c-fms promoter drives transgene (lacZ) expression in astrocytes 35 . The F4/80 antigen is readily detected on brain macrophages (microglial cells) 36 . In the brain, EGFP was detectable in macrophages associated with the microvasculature and meningeal surfaces (not shown) and in microglia (Fig. 6E) . In this organ, microglial processes were clearly evident and highlighted by the fluorescent protein expression. Expression of EGFP in microglia can also be clearly observed in the retina, where they spread in two dimensions in the plane of the inner and outer plexiform layers 28 ( Fig. 6F) . In neither brain, nor retina, was there any evidence of expression in glial cells other than microglia.
Macrophages defined by F4/80 antigen expression are abundantly associated with epithelia and in endocrine organs where they may perform specific physiological functions 26, 30, 37 . In an extensive survey, EGFP expression was generally consistent with previous data on F4/80.
Examples shown include the lamina propria of the gastrointestinal tract (Fig. 6D) , the renal medulla ( Fig. 6G) and interstitium of the testis (Fig. 6H) . A number of additional examples and further images are displayed at www.imb.uq.edu.au/groups/hume. Bone resorptive osteoclasts share a progenitor with macrophages and their production is CSF-1 dependent. Although they lose mature macrophage markers such as F4/80 29 , mature osteoclasts express c-fms mRNA and CSF-1 can acutely-regulate osteoclastic bone resorption [38] [39] [40] . In the transgenic mice, osteoclasts expressed detectable EGFP both in culture and bone sections (Fig. 6I) .
only. (Fig. 6J, arrow) or in en face view in epidermal sheets (Fig. 6K) . In the spleen, the EGFP marker was detectable at low level in cells forming a reticular network within the white pulp, consistent with expression in interdigitating dendritic cells 45 . Similarly, in the mesenteric lymph node, EGFP was expressed at high levels on cells within the medullary cords, where F4/80 is also expressed 27 , but also on presumed interdigitating cells within lymphoid follicles (not shown). The myeloid/dendritic cell component of thymus is complex 46 . EGFP was very abundant in large stellate cells especially concentrated around the cortical medullary junction (Fig.6L ). In the cortex, there was also a network of ramified EGFP expression that may correspond to thymic dendritic cells.
DISCUSSION
Transcriptional regulatory elements of the c-fms gene.
The c-fms gene is expressed in trophoblasts and macrophages in both mice and humans. The first part of this study showed that the underlying mechanisms are different. Whereas the human gene reportedly utilises a promoter in 3' end of the upstream PDGFR-to direct expression in trophoblasts 5, 11 , the mouse gene clearly uses multiple transcription start sites within the 500bp flanking exon 2. This region is actually conserved between mouse and human, and contains elements such as AP-1 sites that have been implicated in trophoblast-specific transcription.
These proximal sequences might contribute to activation of the upstream promoter, or splicing, in the human gene expressed in trophoblasts. The 7.2kb fms promoter could be utilised to direct expression of a trophoblast-specific transgene for functional/immunological studies. Since the upstream promoter is not used in macrophages and is not required for promoter activity in transient transfections 3 , we may be able to selectively delete the trophoblast control elements to eliminate trophoblast expression whilst retaining macrophage promoter activity.
Analysis of multiple independent transgenic lines confirmed that the activity of the 7.2kb
promoter construct was largely, or completely, abolished by either deletion of the first intron or elimination of the FIRE sequence. As observed in stably transfected cell lines 4 , there was detectable residual activity in macrophages with the promoter alone, in keeping with reports of successful use of the corresponding human promoter region to drive low level expression of a transgene 47 . Elimination of FIRE in an intron-containing construct, on the other hand, abolished all activity 4 . We have proposed that FIRE acts to overcome a block to transcription elongation in the first intron 4 , these findings extend the evidence favouring this model to a transgene in vivo.
Based upon the constitutive activity in a wide range of mouse tumor cell lines 3, 13 we might have only.
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By contrast to the data with tumor cells, the 3.5kb promoter was very weakly-active in untransformed 3T3 fibroblasts 12 . The findings with the transgenic mice support the view that constitutive fms promoter activity in tumour lines reflects their malignancy 13 . Interestingly, deletion of the trophoblast promoter region newly-identified herein abolished c-fms promoter function in non-macrophage tumour cells but not in RAW264 cells 13 .
Definition of the mononuclear phagocyte system.
The mononuclear phagocyte system was defined as a family of cells arising from bone marrow progenitors, circulating as monocytes and entering the tissues where they form the resident macrophage population 48 . In the mouse, F4/80, which detects a member of the EGF-TM7 family of surface receptors 49 , has been most widely studied as a marker of tissue macrophages [26] [27] [28] [29] [30] [31] [32] . The Tissue-macrophages are thought to adapt to local environments to perform tissue-specific functions. For example, the interstitial macrophages of the testis shown clearly in Fig. 6H are thought to regulate testosterone production 37 and the CSF-1-deficient mouse has reproductive defects when they are reduced or absent 50 . The transgene marker can be applied conveniently for purification of macrophages from each of these sites for phenotypic analysis. Figs 5 and 6 show the examples using bone marrow progenitor cells, lung interstitial macrophages, intestinal lamina propria and splenic macrophages. Unlike F4/80, which appears only after the liver becomes the major haematopoietic site 21 , the c-fms-EGFP transgene was expressed in phagocyte-like cells throughout development. The expression in the embryo was indistinguishable from our earlier description of the location of c-fms mRNA 7, 8 . We have been able to sort fluorescent cells from enzymatically-digested embryos (not shown), providing the opportunity to delineate further the ways that they differ from macrophages in adult tissues.
Given the central function of CSF-1 in macrophage differentiation, and the lack of macrophages in CSF-1-deficient Csf1 op /Csf1 op mice 44 or in the recently characterised c-fms knock out 51 , the CSF-1R is the most obvious definitive marker for the mononuclear phagocyte lineage. We infer that the expression of c-fms-EGFP correlates with expression of a functional CSF-1 receptor.
Co-localisation of EGFP and surface CSF-1R in bone marrow cells supported this view (Fig. 5 ).
There was a population of cells that were EGFP-positive but lacked detectable surface CSF-1R, but these cells expressed myeloid markers, CD11b and to a lesser extent, F4/80 (Fig. 5) . CSF-1R
is acutely down-modulated from the cell surface by a range of stimuli including ligand 52,53 , whereas EGFP is stable. Hence, it is not surprising that the correlation is imperfect in progenitor cells and proliferating myeloid precursors. In peripheral blood, there was no detectable expression of EGFP in mature granulocytes. In the mononuclear cell fraction, and in peritoneal only.
For evidence that LC and mature DC respond to CSF-1 and that the factor can influence divergence of the macrophage/DC functional fate 42 . We may infer that other factors in particular tissue locations can substitute for CSF-1. Ongoing studies in our laboratory will address the relationship between EGFP expression and other DC markers.
For
Conclusion
We have identified the elements within the c-fms gene required for reproducible expression of a reporter gene in cells of the mononuclear phagocyte lineage. The c-fms-EGFP transgene will be a useful marker for further studies of the biology of the cells in this system.
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